Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:38 PM
Ignite Modification Date:
2025-12-24 @ 3:38 PM
NCT ID:
NCT04756492
Eligibility Criteria:
Inclusion Criteria:
* o Patients diagnosed with LN at Sohag University Hospital
* Patients in regular follow-up for more than six months after immunosuppressive therapy
* Baseline urinary protein/creatinine ratio (UPCR) more than 1 g/g
* Baseline C3 less than 55 mg/ dl
* No change in immunosuppressive therapy within six months
Exclusion Criteria:
* o Patients with incomplete pathological data and the number of glomeruli being \<10 per biopsy specimen
* Age \<14 years old End-stage renal disease (ESRD) status on admission (sustained estimated glomerular filtration rate (eGFR) \<15 ml/min per 1.73m2)
* Patients with advanced comorbid conditions like advanced liver cirrhosis or heart failure or malignancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
60 Years
Study:
NCT04756492
Study Brief:
Protocol Section:
NCT04756492